Akarp, Sweden

Thomas Hogberg


Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Ballerup, DK (2016)
  • Akarp, SE (2016 - 2017)

Company Filing History:


Years Active: 2016-2017

Loading Chart...
4 patents (USPTO):

Title: The Innovative Mind of Thomas Hogberg

Introduction

Thomas Hogberg, an accomplished inventor based in Åkarp, Sweden, has made significant contributions to the field of pharmaceutical sciences. With a total of four patents to his name, he is noted for his innovative methods that advance drug production, specifically in the synthesis of ingenol-3-angelate.

Latest Patents

Hogberg's latest patent focuses on a method of producing ingenol-3-angelate from ingenol. This invention not only details the processes involved in the conversion of ingenol to ingenol-3-angelate but also identifies useful intermediates for this synthesis. The implications of this work could enhance the efficiency of producing essential pharmaceutical compounds, showcasing Hogberg’s expertise in the area.

Career Highlights

Throughout his career, Thomas Hogberg has been associated with prominent companies in the pharmaceutical industry, including Leo Laboratories Limited and Dr. Reddy's Laboratories. His work has been instrumental in enhancing drug formulations and therapeutic applications. With a robust educational background and professional experience, Hogberg has positioned himself as an influential figure in research and development within the sector.

Collaborations

Hogberg has collaborated with esteemed colleagues in his field, including Gunnar Grue-Sorensen and Xifu Liang. These professional relationships have fostered innovation and contributed to the success of various projects over the years. Working alongside talented professionals has allowed Hogberg to broaden his research scope and drive technological advancements.

Conclusion

In summary, Thomas Hogberg is a noteworthy inventor whose innovative contributions to pharmaceutical sciences are underscored by his patents and collaborations. His work in developing methods for the synthesis of ingenol-3-angelate exemplifies his commitment to advancing drug manufacturing processes. As he continues to innovate, Hogberg’s impact on the industry is expected to grow, shaping the future of pharmaceutical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…